Ameriprise’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Sell
226,160
-120,516
-35% -$1.04M ﹤0.01% 3000
2025
Q4
$3.6M Buy
346,676
+19,112
+6% +$201K ﹤0.01% 2672
2025
Q3
$2.9M Buy
327,564
+314,609
+2,428% +$2.24M ﹤0.01% 2785
2025
Q2
$74.8K Buy
12,955
+469
+4% +$2.87K ﹤0.01% 3904
2025
Q1
$82.4K Sell
12,486
-2,440
-16% -$19K ﹤0.01% 3903
2024
Q4
$130K Buy
+14,926
New +$215K ﹤0.01% 3921
2024
Q3
Sell
-182,557
Closed -$3.76M 3975
2024
Q2
$3.76M Buy
+182,557
New +$3.75M ﹤0.01% 2510
2021
Q4
Sell
-2,391,003
Closed -$44.8M 4010
2021
Q3
$44.8M Sell
2,391,003
-90,225
-4% -$1.7M 0.01% 814
2021
Q2
$51.7M Buy
2,481,228
+7,083
+0.3% +$176K 0.02% 789
2021
Q1
$69.9M Buy
2,474,145
+1,416,480
+134% +$44.8M 0.02% 627
2020
Q4
$34.5M Buy
+1,057,665
New +$37.2M 0.01% 912
2018
Q4
Sell
-67,260
Closed -$1.18M 3714
2018
Q3
$1.18M Buy
67,260
+40,620
+152% +$779K ﹤0.01% 3013
2018
Q2
$485K Buy
+26,640
New +$451K ﹤0.01% 3259

Other funds holding KURA